Relation Between Muscle Strength With Exercise Capacity and Dyspnea in LTx
Relation Between Upper and Lower Limb Muscle Strength With Exercise Capacity and Dyspnea in Patients With Awaiting Lung Transplantation
1 other identifier
interventional
25
1 country
1
Brief Summary
Severe exercise intolerance and shortness of breath are present in lung transplant candidates. Clinical features that reveal these symptoms in terminal period lung patients vary and are unclear. The effect of peripheral muscle strength on exercise capacity and dyspnea will be examined in our study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2018
CompletedFirst Posted
Study publicly available on registry
September 12, 2018
CompletedStudy Start
First participant enrolled
September 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedDecember 2, 2019
October 1, 2018
11 months
September 11, 2018
November 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes from baseline the muscle strength
Muscle strength will measure using a digital dynamometer (J-Tech Commander muscle testing device), wth three measurements make. Best result will be taken.
15 minutes
Changes from baseline the hand grip strength.
It was measured with hydraulic hand dynamometer calibrated in lbs.
5 minutes
Changes from baseline the maximum inspiratory muscle pressure
The mouth pressure measurement was performed with the Micro-RPM® instrument from SensorMEDIC. Patient placed a rubber mouthpiece with flanges, on the device, sealed their lips firmly around the mouthpiece, exhaled/inhaled slowly and completely, and then tried to breath in as hard as possible. The patient was allowed to rest for about a minute and the maneuver was repeated five times. Verbal or visual feedback was provided after each maneuver. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value was obtained.
15 minutes
Changes from baseline the distance covered in six-minute walk test
The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were told that they should walk as fast as they can walk. Before and after the test, oxygen saturation, heart rate, Borg fatigue rating, and walking distance were recorded.
20 minutes
Changes from baseline the modified Medical Research Council (mMRC) scale
The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. "O" means no dyspnea perception, "4" means severe dyspnea perception.
5 minutes
Study Arms (1)
Pulmonary Rehabilitation
EXPERIMENTALA 6-min walk test, peripheral and respiratory muscle strength measurements, and a dyspnea rating scale Mmrc will be applied to the lung transplantation candidates who are trained in 3-month hospital-based preoperative exercise training in the Pulmonary Rehabilitation unit. The tests will be carried out at the beginning and end of rehabilitation.
Interventions
A 6-min walk test, peripheral and respiratory muscle strength measurements, and a dyspnea rating scale Mmrc will be applied to the lung transplantation candidates who are trained in 3-month hospital-based preoperative exercise training in the Pulmonary Rehabilitation unit. The tests will be carried out at the beginning and end of rehabilitation.
Eligibility Criteria
You may qualify if:
- have a diagnosis of terminally severe lung disease,
- being listed for lung transplantation,
- medically stable,
- had no orthopedic or cardiac problems that would prevent them from exercising
- had no transfer problem to the pulmonary rehabilitation center.
You may not qualify if:
- Dont except to participate the study
- incompatibility with exhaust
- not completing the program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, 34200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 11, 2018
First Posted
September 12, 2018
Study Start
September 20, 2018
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
December 2, 2019
Record last verified: 2018-10